相似文献
1
Reply: β2-agonists and acute respiratory distress syndrome.
Am J Respir Crit Care Med. 2014 Jun 1;189(11):1448. doi: 10.1164/rccm.201404-0644LE.
2
Reply: Importance of the kidney, vessels, and heart with administration of β2 adrenergic receptor agonists in patients susceptible to acute respiratory distress syndrome.
Am J Respir Crit Care Med. 2014 Jun 1;189(11):1447-8. doi: 10.1164/rccm.201404-0654LE.
3
β2-agonists and acute respiratory distress syndrome.
Am J Respir Crit Care Med. 2014 Mar 15;189(6):624-5. doi: 10.1164/rccm.201401-0170ED.
4
Importance of the kidney, vessels, and heart with administration of β2 adrenergic receptor agonists in patients susceptible to acute respiratory distress syndrome.
Am J Respir Crit Care Med. 2014 Jun 1;189(11):1445-7. doi: 10.1164/rccm.201404-0610LE.
5
The beta agonist lung injury trial prevention. A randomized controlled trial.
Am J Respir Crit Care Med. 2014 Mar 15;189(6):674-83. doi: 10.1164/rccm.201308-1549OC.
6
First do no harm: surrogate endpoints and the lesson of β-agonists in acute lung injury.
Crit Care. 2012 Jun 26;16(3):314. doi: 10.1186/CC11392.
7
Long acting β2 agonists in adult asthma.
BMJ. 2013 Aug 6;347:f4662. doi: 10.1136/bmj.f4662.
8
Con: β2-adrenergic agonists in ALI/ARDS--not recommended or potentially harmful?
Am J Respir Crit Care Med. 2011 Sep 1;184(5):504-6. doi: 10.1164/rccm.201105-0852ED.
9
Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury.
Crit Care Med. 2004 Jul;32(7):1470-6. doi: 10.1097/01.ccm.0000129489.34416.0e.
10
Lung injury prediction models to improve perioperative management: let's hit the bull's-eye!
Anesthesiology. 2011 Jul;115(1):10-1. doi: 10.1097/ALN.0b013e31821b586b.
引用本文的文献
1
The potential role of carvedilol in COVID-19 management: perspective and take-away.
Inflammopharmacology. 2025 Aug 27. doi: 10.1007/s10787-025-01909-5.
2
Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
Front Immunol. 2021 Nov 11;12:749291. doi: 10.3389/fimmu.2021.749291. eCollection 2021.
本文引用的文献
1
β₂-Adrenergic agonists augment air pollution-induced IL-6 release and thrombosis.
J Clin Invest. 2014 Jul;124(7):2935-46. doi: 10.1172/JCI75157. Epub 2014 May 27.
2
β2-agonists and acute respiratory distress syndrome.
Am J Respir Crit Care Med. 2014 Mar 15;189(6):624-5. doi: 10.1164/rccm.201401-0170ED.
3
The beta agonist lung injury trial prevention. A randomized controlled trial.
Am J Respir Crit Care Med. 2014 Mar 15;189(6):674-83. doi: 10.1164/rccm.201308-1549OC.
4
Prone positioning in severe acute respiratory distress syndrome.
N Engl J Med. 2013 Jun 6;368(23):2159-68. doi: 10.1056/NEJMoa1214103. Epub 2013 May 20.
5
Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial.
Lancet. 2012 Jan 21;379(9812):229-35. doi: 10.1016/S0140-6736(11)61623-1. Epub 2011 Dec 11.
6
Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury.
Am J Respir Crit Care Med. 2011 Sep 1;184(5):561-8. doi: 10.1164/rccm.201012-2090OC.
7
Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis.
JAMA. 2010 Mar 3;303(9):865-73. doi: 10.1001/jama.2010.218.
8
Comparison of two fluid-management strategies in acute lung injury.
N Engl J Med. 2006 Jun 15;354(24):2564-75. doi: 10.1056/NEJMoa062200. Epub 2006 May 21.
9
The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial.
Am J Respir Crit Care Med. 2006 Feb 1;173(3):281-7. doi: 10.1164/rccm.200508-1302OC. Epub 2005 Oct 27.
10
Neural control of renal function.
Physiol Rev. 1997 Jan;77(1):75-197. doi: 10.1152/physrev.1997.77.1.75.
Zotero 插件